nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—BCHE—Irinotecan—colon cancer	0.585	1	CbGbCtD
Mivacurium—CHRM3—ureter—colon cancer	0.116	0.374	CbGeAlD
Mivacurium—CHRM3—muscle of abdomen—colon cancer	0.0835	0.269	CbGeAlD
Mivacurium—CHRNA1—lymphoid tissue—colon cancer	0.019	0.0613	CbGeAlD
Mivacurium—CHRNB1—vagina—colon cancer	0.0128	0.0413	CbGeAlD
Mivacurium—Hypoxemia—Methotrexate—colon cancer	0.0112	0.106	CcSEcCtD
Mivacurium—CHRNB1—liver—colon cancer	0.0108	0.0348	CbGeAlD
Mivacurium—CHRM3—smooth muscle tissue—colon cancer	0.00958	0.0309	CbGeAlD
Mivacurium—CHRM3—renal system—colon cancer	0.00922	0.0297	CbGeAlD
Mivacurium—CHRNB1—lymph node—colon cancer	0.00828	0.0267	CbGeAlD
Mivacurium—BCHE—smooth muscle tissue—colon cancer	0.00782	0.0252	CbGeAlD
Mivacurium—CHRM3—digestive system—colon cancer	0.00756	0.0244	CbGeAlD
Mivacurium—BCHE—digestive system—colon cancer	0.00617	0.0199	CbGeAlD
Mivacurium—BCHE—bone marrow—colon cancer	0.00569	0.0184	CbGeAlD
Mivacurium—BCHE—vagina—colon cancer	0.00545	0.0176	CbGeAlD
Mivacurium—BCHE—liver—colon cancer	0.0046	0.0148	CbGeAlD
Mivacurium—BCHE—lymph node—colon cancer	0.00353	0.0114	CbGeAlD
Mivacurium—Hypoxia—Methotrexate—colon cancer	0.00353	0.0336	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Irinotecan—colon cancer	0.00337	0.0322	CcSEcCtD
Mivacurium—Injection site reaction—Capecitabine—colon cancer	0.00299	0.0285	CcSEcCtD
Mivacurium—Phlebitis—Capecitabine—colon cancer	0.00254	0.0242	CcSEcCtD
Mivacurium—Bradycardia—Irinotecan—colon cancer	0.0023	0.0219	CcSEcCtD
Mivacurium—Cardiac disorder—Vincristine—colon cancer	0.00215	0.0205	CcSEcCtD
Mivacurium—Angiopathy—Vincristine—colon cancer	0.0021	0.0201	CcSEcCtD
Mivacurium—Cardiac disorder—Irinotecan—colon cancer	0.0021	0.02	CcSEcCtD
Mivacurium—Flushing—Irinotecan—colon cancer	0.0021	0.02	CcSEcCtD
Mivacurium—Mediastinal disorder—Vincristine—colon cancer	0.00209	0.0199	CcSEcCtD
Mivacurium—Angiopathy—Irinotecan—colon cancer	0.00205	0.0195	CcSEcCtD
Mivacurium—Immune system disorder—Irinotecan—colon cancer	0.00204	0.0194	CcSEcCtD
Mivacurium—Mediastinal disorder—Irinotecan—colon cancer	0.00203	0.0194	CcSEcCtD
Mivacurium—Arrhythmia—Irinotecan—colon cancer	0.00202	0.0192	CcSEcCtD
Mivacurium—Arrhythmia—Fluorouracil—colon cancer	0.00193	0.0184	CcSEcCtD
Mivacurium—Muscle spasms—Irinotecan—colon cancer	0.00189	0.018	CcSEcCtD
Mivacurium—Erythema—Fluorouracil—colon cancer	0.00188	0.0179	CcSEcCtD
Mivacurium—Bronchospasm—Capecitabine—colon cancer	0.00186	0.0177	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Methotrexate—colon cancer	0.00168	0.016	CcSEcCtD
Mivacurium—Anaphylactic shock—Vincristine—colon cancer	0.00165	0.0157	CcSEcCtD
Mivacurium—Anaphylactic shock—Irinotecan—colon cancer	0.0016	0.0153	CcSEcCtD
Mivacurium—Hypotension—Vincristine—colon cancer	0.00154	0.0147	CcSEcCtD
Mivacurium—Bradycardia—Capecitabine—colon cancer	0.00154	0.0147	CcSEcCtD
Mivacurium—Anaphylactic shock—Fluorouracil—colon cancer	0.00154	0.0146	CcSEcCtD
Mivacurium—Tachycardia—Fluorouracil—colon cancer	0.0015	0.0143	CcSEcCtD
Mivacurium—Hypotension—Irinotecan—colon cancer	0.0015	0.0143	CcSEcCtD
Mivacurium—Hypotension—Fluorouracil—colon cancer	0.00144	0.0137	CcSEcCtD
Mivacurium—Cardiac disorder—Capecitabine—colon cancer	0.0014	0.0134	CcSEcCtD
Mivacurium—Flushing—Capecitabine—colon cancer	0.0014	0.0134	CcSEcCtD
Mivacurium—Angiopathy—Capecitabine—colon cancer	0.00137	0.0131	CcSEcCtD
Mivacurium—Immune system disorder—Capecitabine—colon cancer	0.00136	0.013	CcSEcCtD
Mivacurium—Mediastinal disorder—Capecitabine—colon cancer	0.00136	0.013	CcSEcCtD
Mivacurium—Arrhythmia—Capecitabine—colon cancer	0.00135	0.0129	CcSEcCtD
Mivacurium—Erythema—Capecitabine—colon cancer	0.00132	0.0125	CcSEcCtD
Mivacurium—Muscle spasms—Capecitabine—colon cancer	0.00126	0.0121	CcSEcCtD
Mivacurium—Urticaria—Fluorouracil—colon cancer	0.00122	0.0116	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00111	0.0106	CcSEcCtD
Mivacurium—Dizziness—Vincristine—colon cancer	0.00109	0.0104	CcSEcCtD
Mivacurium—Dizziness—Irinotecan—colon cancer	0.00106	0.0101	CcSEcCtD
Mivacurium—Tachycardia—Capecitabine—colon cancer	0.00105	0.00999	CcSEcCtD
Mivacurium—Cardiac disorder—Methotrexate—colon cancer	0.00104	0.00995	CcSEcCtD
Mivacurium—Skin disorder—Capecitabine—colon cancer	0.00104	0.00994	CcSEcCtD
Mivacurium—Rash—Vincristine—colon cancer	0.00104	0.0099	CcSEcCtD
Mivacurium—Dermatitis—Vincristine—colon cancer	0.00104	0.00989	CcSEcCtD
Mivacurium—Angiopathy—Methotrexate—colon cancer	0.00102	0.00973	CcSEcCtD
Mivacurium—Immune system disorder—Methotrexate—colon cancer	0.00102	0.00969	CcSEcCtD
Mivacurium—Dizziness—Fluorouracil—colon cancer	0.00102	0.00969	CcSEcCtD
Mivacurium—Mediastinal disorder—Methotrexate—colon cancer	0.00101	0.00967	CcSEcCtD
Mivacurium—Rash—Irinotecan—colon cancer	0.00101	0.00964	CcSEcCtD
Mivacurium—Dermatitis—Irinotecan—colon cancer	0.00101	0.00963	CcSEcCtD
Mivacurium—Hypotension—Capecitabine—colon cancer	0.001	0.00957	CcSEcCtD
Mivacurium—Erythema—Methotrexate—colon cancer	0.000979	0.00934	CcSEcCtD
Mivacurium—Rash—Fluorouracil—colon cancer	0.000969	0.00924	CcSEcCtD
Mivacurium—Dermatitis—Fluorouracil—colon cancer	0.000968	0.00923	CcSEcCtD
Mivacurium—Urticaria—Capecitabine—colon cancer	0.000853	0.00813	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000828	0.00789	CcSEcCtD
Mivacurium—Anaphylactic shock—Methotrexate—colon cancer	0.000799	0.00762	CcSEcCtD
Mivacurium—Skin disorder—Methotrexate—colon cancer	0.000776	0.0074	CcSEcCtD
Mivacurium—Hypotension—Methotrexate—colon cancer	0.000747	0.00712	CcSEcCtD
Mivacurium—Dizziness—Capecitabine—colon cancer	0.00071	0.00677	CcSEcCtD
Mivacurium—Rash—Capecitabine—colon cancer	0.000677	0.00645	CcSEcCtD
Mivacurium—Dermatitis—Capecitabine—colon cancer	0.000676	0.00645	CcSEcCtD
Mivacurium—Urticaria—Methotrexate—colon cancer	0.000635	0.00605	CcSEcCtD
Mivacurium—Dizziness—Methotrexate—colon cancer	0.000528	0.00504	CcSEcCtD
Mivacurium—Rash—Methotrexate—colon cancer	0.000504	0.0048	CcSEcCtD
Mivacurium—Dermatitis—Methotrexate—colon cancer	0.000503	0.0048	CcSEcCtD
